Diet Induced Intestinal Mucosal Adaptation

NCT ID: NCT02088853

Last Updated: 2025-07-17

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

17 participants

Study Classification

INTERVENTIONAL

Study Start Date

2014-03-31

Study Completion Date

2014-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Human beings are 'omnivores' meaning that all principal components of food (i.e. the macronutrients: carbohydrates, fat, proteins) can be assimilated by the gastrointestinal tract. When the gut mucosa is exposed to dietary changes it adjusts its functional behaviour. For example, a fatty diet demands certain digestive mechanisms, whereas others are needed to take care of a carbohydrate rich diet. Such dietary induced changes in appearance and functionality of the small intestinal mucosa have been described in animals but only little is known about it in man. The present project aims at elucidating in man if a 2 weeks diet dominated by either fat or carbohydrates, but with similar energy content, is associated with changes in the small intestinal mucosal appearance and metabolic signalling capacity.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Healthy Conditions

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

CROSSOVER

Primary Study Purpose

BASIC_SCIENCE

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

First high fat diet, then high carbohydrate diet

had; first sixty percent fat as the energy source, then sixty percent carbohydrates

Group Type EXPERIMENTAL

high fat diet (hfd), then high carbohydrate diet

Intervention Type DIETARY_SUPPLEMENT

Sixty % of the energy content is based on fat, then sixty % of the energy content is based on carbohydrates

First, high carb diet, then high fat diet

had; first sixty percent carbohydrates as the energy source, the sixty percent fat

Group Type EXPERIMENTAL

high carbohydrate diet, then high fat diet

Intervention Type DIETARY_SUPPLEMENT

Sixty % of the energy content is based on carbohydrates, then sixty % of the energy content is based on fat

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

high fat diet (hfd), then high carbohydrate diet

Sixty % of the energy content is based on fat, then sixty % of the energy content is based on carbohydrates

Intervention Type DIETARY_SUPPLEMENT

high carbohydrate diet, then high fat diet

Sixty % of the energy content is based on carbohydrates, then sixty % of the energy content is based on fat

Intervention Type DIETARY_SUPPLEMENT

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

healthy volunteer not taking prescribed medications BMI ≤25 kg/m2

Exclusion Criteria

BMI ≥26 kg/m2 smoker previous or current gastrointestinal disease significant abdominal surgery pregnancy/breast feeding drug intolerance of importance (particularly opiates and midazolam used during endoscopy) history of drug addiction
Minimum Eligible Age

18 Years

Maximum Eligible Age

65 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Sahlgrenska University Hospital

OTHER

Sponsor Role collaborator

Göteborg University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Lars Fändriks, MD, PhD

Role: PRINCIPAL_INVESTIGATOR

Göteborg University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Dept of Gastrosurgical R&E, Sahlgrenska Universityhospital

Gothenburg, , Sweden

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Sweden

References

Explore related publications, articles, or registry entries linked to this study.

Elebring E, Wallenius V, Casselbrant A, Docherty NG, Roux CWL, Marschall HU, Fandriks L. A Fatty Diet Induces a Jejunal Ketogenesis Which Inhibits Local SGLT1-Based Glucose Transport via an Acetylation Mechanism-Results from a Randomized Cross-Over Study between Iso-Caloric High-Fat versus High-Carbohydrate Diets in Healthy Volunteers. Nutrients. 2022 May 7;14(9):1961. doi: 10.3390/nu14091961.

Reference Type DERIVED
PMID: 35565929 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

BUTTER

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Food Effects on the Gut Microbiota
NCT03078283 COMPLETED NA